Atai Life Sciences N.V. (ATAI) Stock Price, Quote & News

Company Profile

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b...

Industry: Biotechnology

Sector: Healthcare

Phone: 49 89 2153 9035

Website: atai.com

Address:

Wallstraße 16, Berlin, Germany

DriuxP Aug. 6 at 10:50 PM

$ATAI picked up some at $3.80 today. Not much. It's the thought that counts 😁

0 · Reply

Vynfred Aug. 6 at 9:40 PM

$ATAI buy anything under $4... I'm guessing earnings will be on target giving an extra bit of momentum to push over $5... and $8 by EOY

1 · Reply

McGuireTO Aug. 6 at 8:46 PM

$ATAI bulls bounce hard from hourly oversold ATAI bulls bounced hard from the daily EMA12 at hourly oversold conditions, V-shape bounce into hew high of day with a close at the high. This is the highest close in well over 3 years! We haven't yet changed the hourly trend back to bullish, but we did end the downtrend. I got a lot of information from today's price action and tomorrow's price action will be equally important as well, as we will need to form an hourly higher low above today's low and change the hourly trend back to bullish. I publish regular technical analysis of the shrooms sector, be sure to like and follow so you don't miss future updates! https://www.tradingview.com/chart/ATAI/SpL7vkpF-ATAI-bulls-bounce-hard-from-hourly-oversold/

1 · Reply

Mcahill Aug. 6 at 8:06 PM

$ATAI when is earnings call?

1 · Reply

guppyguru Aug. 6 at 8:01 PM

$ATAI that price action jeez, come down touch the 10 dma and close green at the high of the day

1 · Reply

Tadhg1274 Aug. 6 at 7:34 PM

$ATAI any guesses for price after earnings call?

0 · Reply

jattboy Aug. 6 at 7:22 PM

$ATAI what do u folks think will be the high price point for the remainder of the week?

1 · Reply

matrixtrade123 Aug. 6 at 7:14 PM

$ATAI this will be our 5th straight day closing above $4 dollars a share & I am excited as Hell __ I really do hope this can become another of Theil's Meme Stocks ala Palantir __ and lets not forget the Real Team Christian & Cosmo to form ATAI Beckley __ these are AMAZING TIMES indeed !

0 · Reply

theimpatienttrader Aug. 6 at 6:47 PM

$ATAI is it wrong of me to want this to go down so I can buy more it's in option killing mode sooooo

0 · Reply

matrixtrade123 Aug. 6 at 6:41 PM

$ATAI I am satisfied with the stock performance of my ATAI Life Sciences today and actually this week after that after hours poo poo. They really know how to stick it to the Retai Traders but we were not punked. Stay Strong!

0 · Reply

Atai: Inidascamine Trial Failure Doesn't Matter In Main Psychedelic Pipeline Focus

Jul 28, 2025, 10:58 AM EDT - 9 days ago

Why Is ATAI Life Sciences Stock Trading Lower On Monday?

Jul 28, 2025, 8:13 AM EDT - 9 days ago

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

RVTY

Jul 25, 2025, 4:16 PM EDT - 12 days ago

Atai Life Sciences schizophrenia drug fails to meet main goal in mid-stage trial

Jul 25, 2025, 4:05 PM EDT - 12 days ago

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia

Jul 2, 2025, 2:29 PM EDT - 5 weeks ago

Atai: Critical Study Win Sets Up Double Approval Shot For Psychedelics In TRD

Jul 1, 2025, 9:28 AM EDT - 5 weeks ago

Atai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage Data

Jul 1, 2025, 6:05 AM EDT - 5 weeks ago

atai Life Sciences Announces $50 Million Private Placement Financing

Jul 1, 2025, 6:00 AM EDT - 5 weeks ago

atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression

Jun 2, 2025, 6:00 AM EDT - 2 months ago

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies

May 29, 2025, 8:30 AM EDT - 2 months ago

atai Life Sciences to Participate in Upcoming Investor Conferences

May 20, 2025, 7:00 AM EDT - 2 months ago

atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech's Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression

May 14, 2025, 7:00 AM EDT - 3 months ago

atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates

May 13, 2025, 7:01 AM EDT - 3 months ago

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder

Mar 11, 2025, 7:00 AM EDT - 5 months ago

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression

Feb 27, 2025, 12:45 PM EST - 5 months ago

Atai: Following The Path That Spravato Laid And Moving Beyond It

Feb 24, 2025, 4:10 PM EST - 5 months ago

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 20, 2025, 7:00 AM EST - 5 months ago

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

Feb 12, 2025, 10:47 PM EST - 6 months ago

atai Life Sciences Announces Pricing of Public Offering of Common Shares

Feb 12, 2025, 4:01 PM EST - 6 months ago

atai Life Sciences Announces Proposed Public Offering of Common Shares

Jan 29, 2025, 11:57 AM EST - 6 months ago

Atai Life Sciences: Positive BPL-003 Data In AUD Leads To Another Catalyst

Jan 10, 2025, 7:00 AM EST - 7 months ago

atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health

Oct 2, 2024, 9:21 AM EDT - 11 months ago

IntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AG

Sep 4, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Sep 3, 2024, 2:00 PM EDT - 1 year ago

Psychedelic Stock Deep Dive: Atai Life Sciences

Aug 13, 2024, 7:10 AM EDT - 1 year ago

atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Aug 12, 2024, 12:12 PM EDT - 1 year ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

CMPS CYBN MNMD

Aug 7, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference

Jun 26, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference

Jun 20, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences Announces Update on Beckley Psytech's Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a

May 31, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference

May 15, 2024, 6:59 AM EDT - 1 year ago

atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates

Apr 24, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech's Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression

Apr 17, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences Announces the Publication of Beckley Psytech's Phase 1 Study of BPL-003 in the Journal of Psychopharmacology

Mar 28, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights

Mar 27, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences Announces Positive Initial Results from Beckley Psytech's Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression

Mar 4, 2024, 8:00 AM EST - 1 year ago

atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01

Feb 28, 2024, 5:00 PM EST - 1 year ago

atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference

Feb 6, 2024, 5:00 PM EST - 1 year ago

atai Life Sciences Appoints Anne Johnson as Chief Financial Officer

Jan 4, 2024, 7:00 AM EST - 1 year ago

atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics

Nov 29, 2023, 6:55 PM EST - 1 year ago

Atai Life Sciences: A Promising Venture In The Psychedelic Therapy Market Trading Below Cash Value

Nov 14, 2023, 7:03 AM EST - 1 year ago

atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights

Oct 6, 2023, 4:05 PM EDT - 1 year ago

atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit

Oct 2, 2023, 4:13 PM EDT - 2 years ago

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants

Sep 14, 2023, 8:02 AM EDT - 2 years ago

atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

Sep 6, 2023, 4:01 PM EDT - 2 years ago

atai Life Sciences to Participate in Upcoming September Investor Conferences

Sep 1, 2023, 7:02 PM EDT - 2 years ago

Atai Life Sciences: RL-007, Targeting Schizophrenia Subpopulation With No FDA Approved Therapies

Aug 10, 2023, 6:59 AM EDT - 2 years ago

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

Aug 8, 2023, 4:02 PM EDT - 2 years ago

atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

DriuxP Aug. 6 at 10:50 PM

$ATAI picked up some at $3.80 today. Not much. It's the thought that counts 😁

0 · Reply

Vynfred Aug. 6 at 9:40 PM

$ATAI buy anything under $4... I'm guessing earnings will be on target giving an extra bit of momentum to push over $5... and $8 by EOY

1 · Reply

McGuireTO Aug. 6 at 8:46 PM

1 · Reply

Mcahill Aug. 6 at 8:06 PM

$ATAI when is earnings call?

1 · Reply

guppyguru Aug. 6 at 8:01 PM

$ATAI that price action jeez, come down touch the 10 dma and close green at the high of the day

1 · Reply

Tadhg1274 Aug. 6 at 7:34 PM

$ATAI any guesses for price after earnings call?

0 · Reply

jattboy Aug. 6 at 7:22 PM

$ATAI what do u folks think will be the high price point for the remainder of the week?

1 · Reply

matrixtrade123 Aug. 6 at 7:14 PM

0 · Reply

theimpatienttrader Aug. 6 at 6:47 PM

$ATAI is it wrong of me to want this to go down so I can buy more it's in option killing mode sooooo

0 · Reply

matrixtrade123 Aug. 6 at 6:41 PM

0 · Reply

brodobagginz Aug. 6 at 6:28 PM

$ATAI $CMPS wondering why these two are inching closer to parity - seems a little buy-out ish to me...

2 · Reply

RSINVESTOR37 Aug. 6 at 5:41 PM

$ATAI What. A. Beast

0 · Reply

Cat666 Aug. 6 at 5:33 PM

$ATAI can this turn positive by EOD?

1 · Reply

Wallstreetiscriminal Aug. 6 at 5:27 PM

$ATAI Why didn’t you just buy when it was at $3.78 like I did? Lol

1 · Reply

duhbledown11 Aug. 6 at 4:52 PM

$ATAI I have a limit order for $3.89 today

0 · Reply

Kilocharlie Aug. 6 at 3:32 PM

$ATAI

1 · Reply

Cat666 Aug. 6 at 2:46 PM

$ATAI we know he will not do it ..."President Donald Trump threatened to levy tariffs of up to 250% on pharmaceuticals imported into the United States." ...but is this playing a part today?

1 · Reply

nick_m Aug. 6 at 2:45 PM

$ATAI grab some more

0 · Reply

TheLearnerEarner Aug. 6 at 2:38 PM

$ATAI ✅ Healthcare - Mid Cap - Momentum Trap Analysts: 9x buy rating 👨‍🔬 Potential: $16 analyst price target - 316% upside 💠 Range (12m) $1.03 - $4.29 💰 RSI (14): 64.39 (bullish) 📊 NEWSDESK (last recent article) 📰 https://uk.finance.yahoo.com/news/h-c-wainwright-lifts-pt-034028746.html

0 · Reply

twiggs462 Aug. 6 at 2:33 PM

$ATAI These gap downs are great :)

0 · Reply

RSINVESTOR37 Aug. 6 at 2:28 PM

$ATAI dip before earnings could be good, I will not buy but Im looking

1 · Reply

McGuireTO Aug. 6 at 1:52 PM

$MDMA.CSE PharmAla Already traded 30% of yesterday's volume 👀 $ATAI

0 · Reply

Market Cap	853.44M
Revenue (ttm)	310,000.00
Net Income (ttm)	-149.27M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-48,151.61%
Debt to Equity Ratio	0.14

Volume	6,806,500
Avg Vol	5,706,852
Day's Range	N/A - N/A
Shares Out	200.34M
Stochastic %K	81%
Beta	1.54
Analysts	Strong Sell
Price Target	$10.50